Metabolism and Bone Health.
Phase of Trial: Phase I
Latest Information Update: 03 Jun 2015
At a glance
- Drugs Genistein (Primary) ; Isoflavones (Primary) ; Risedronic acid (Primary) ; Daidzein
- Indications Bone resorption; Postmenopausal osteoporosis
- Focus Therapeutic Use
- 07 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Sep 2011 Results presented at the 33rd Annual Meeting of the American Society for Bone and Mineral Research.
- 29 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.